Listed pet care firms post modest gains as resilience holds

Listed pet care companies delivered only modest gains over the last 12 months, with the Global Pet Care Index posting a 3.16% gross return, according to GlobalPETS’ latest sector analysis. The takeaway from the report is less about breakout performance than about durability: pet care appears to be holding up better than many might expect despite market volatility, cost pressure tied in part to energy and oil prices, and uneven results across public companies. Separate reporting from GlobalPETS on H&H Group points in the same direction. H&H said its Pet Nutrition and Care business grew 8.7% to RMB 2.5 billion in FY2025, led by Zesty Paws, even as margin pressure remained a concern. H&H’s filings show the company has continued to lean into higher-margin supplements and premium products, while broadening distribution and refinancing debt to strengthen liquidity. (hkexnews.hk)

Why it matters: For veterinary professionals, this is another sign that companion animal spending is still relatively resilient, but increasingly selective. Public-market performance suggests investors are rewarding steadier, margin-defensible businesses rather than pure growth stories, while company disclosures point to continued demand for premium nutrition, supplements, and health-adjacent products. That matters in clinic and hospital settings because it supports the broader case that pet parents are still spending on preventive and wellness-oriented care, even as operators across the sector face higher input, labor, and distribution costs. Trade and tariff uncertainty has also been flagged as a cost risk for pet-related companies, reinforcing the possibility of continued pricing pressure across the care ecosystem. (gabelli.com)

What to watch: Watch upcoming earnings for signs that margin recovery, not just revenue growth, is becoming the sector’s next test, especially in supplements, premium nutrition, and veterinary-adjacent services. (hkexnews.hk)